Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Eli Lilly and Company
Current Parent Company: Eli Lilly
Penalty: $500,000,000
Year: 2007
Date: January 4, 2007
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Lilly agreed to pay $500 million to settle multi-district litigation alleging that its schizophrenia medication Zyprexa caused diabetes. This amount, covering about 18,000 claims, was in addition to $690 million it agreed to pay in 2005 to cover more than 8,000 earlier suits (see separate Violation Tracker entry). The company's announcement was included on page 36 in this SEC filing: (click here)
Level of Government: federal
Action Type: private litigation
Court: Eastern District of New York
Civil or Criminal Case: civil
Case ID: 1:04md1596
Case Name: In Re: Zyprexa Products Liability Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: Indiana
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.